INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEM

Core Viewpoint - A class action lawsuit has been filed against Tempus AI, Inc. regarding allegations of securities fraud and unlawful business practices [2][3]. Group 1: Lawsuit Details - The lawsuit involves claims that Tempus and certain officers and directors engaged in securities fraud or other unlawful business practices [2]. - Investors who purchased Tempus securities during the Class Period have until August 12, 2025, to request to be appointed as Lead Plaintiff [3]. Group 2: Concerns Raised - A report by Spruce Point Capital Management on May 28, 2025, raised concerns about Tempus, including aggressive accounting and financial reporting practices [3]. - The report also highlighted that several members of Tempus's Board and executives have been associated with companies that restated financial results [3]. - Key strategic partnerships and deal announcements with AstraZeneca and Pathos AI are under scrutiny according to the report [3]. Group 3: Company Background - Pomerantz LLP, the firm handling the lawsuit, is recognized for its expertise in corporate, securities, and antitrust class litigation, with a history of recovering multimillion-dollar damages for class members [4].